Page 5 - Flipbook
P. 5
Editorial Committee
Name Specialty Disclosures
Advisory board: Astellas, Amgen, AbbVie, AstraZeneca, Bayer, Ferring, Janssen,
Sanofi, TerSera
Speakers’ bureau: Amgen, Astellas, Bayer, Ferring, Janssen
Dr Ricardo Rendon Uro-oncologist
Grant/Honorarium: Astellas, Amgen, Bayer, Janssen
Clinical trial: AbbVie, Amgen, Astellas, AstraZeneca, Ferring, Janssen, Pfizer,
Sanofi, Myovant
Honoraria (consulting): Astellas, Bayer, BMS, Eisai, EMD Serono, Ipsen, Janssen,
Dr Krista Noonan Medical oncologist
Merck, Novartis, Pfizer, Roche, TerSera
Honoraria (consulting): AbbVie, Astellas, Bayer, BMS, Eisai, Ipsen, Janssen, Merck,
Novartis, Pfizer, Roche, TerSera
Dr Aly-Khan Lalani Medical oncologist
Grants (all funds to institution): BioCanRx, BMS, Novartis, Roche, Ipsen, EMD
Serono
Honoraria (consulting / advisory board): Astellas, Janssen, Bayer, Elekta, TerSera,
Dr Guila Delouya Radiation oncologist AbbVie, Sanofi, Ferring
Research grant: Janssen